Title Image

Our virtual trip to the USA

Our virtual trip to the USA

Dynamic42 in the USA

We want to take the plunge across the pond! From 06/28 to 07/01/2021 we participated in the intensive workshop Step USA Virtual. It is a very successful and highly informative program that focuses on facilitating market access in the USA for young innovative companies from Germany. The concept was launched by the German American Chamber of Commerce New York (GACC NY) and took place in cooperation with the Frankfurt Main Chamber of Industry and Commerce, the Hessian Ministry of Economic Affairs, Energy, Transport and Housing, the Start Hub Hessen, the TechQuartier, the Stiftung für Technologie, Innovation und Forschung Thüringen (STIFT) and bm-t beteiligungsmanagement thüringen gmbh.

Our managing directors Dr. Martin Raasch and Dr. Knut Rennert received an excellent overview of the US market and learned where the special challenges lie and where they can receive support. “We gained insights into American customs and cultural differences and were able to practice how to pitch your corporate philosophy/vision in front of an American investor. In addition, we learned which legal requirements must be fulfilled for a company to be founded in the USA. One fact became clear: trust is more likely to be placed in a US subsidiary than in an unknown German start-up.

We were accompanied by Andrea Diewald and Irene Fuchs from GACC NY as well as a very good mix of speakers from a wide variety of specialist areas. We would like to thank the organizers of the Step USA Workshop for the successful event, which was very profitable for us.

More interesting articles:

Blog

We are looking forward to two new colleagues for our research and laboratory team!

Read More
Blog

The award underlines that we guarantee high quality standards in the development, production, and distribution of biochips as well as in the services of organ-on-chip models.

Read More
Blog

What does it mean to work with organ-on-chip? What is 3R? Where are the opportunities and benefits for understanding human cellular mechanisms, modeling human diseases, and screening drugs?

Read More